Earnings Call · Q4 FY2023·2024-03-05

Q4 23EPS -10.26%·Rev n/aQ3 23EPS -6.87%·Rev n/aQ2 23EPS -18.10%·Rev n/aQ1 23EPS -16.13%·Rev n/a⚠ consensus missing

Bionano Genomics, Inc. BNGO

David Holmes — Investor Relations

Erik Holmlin — Chief Executive Officer

Gulsen Kama — Chief Financial Officer

+7.2%1d on move date+5.8% vs SPY3d−7.2%5d−18.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BNGO calls or request research access.

More BNGO calls Browse calls Request research access